BIAL in the World
Investment on internationalisation is one of the main strategies of the BIAL group. In recent years, we have extended our presence around the world. Today, our products are marketed in more than 50 countries.
Europe
In Europe, BIAL has a production and R&D unit in Portugal and affiliates in Spain, Germany, United Kingdom, Italy and Switzerland.
In 1998, the group acquired a Spanish pharmaceutical company, becoming BIAL Spain. Currently, BIAL Spain markets a range of products focused on neurology, internal medicine, cardiology and women’s health.
The company has opened affiliates in Germany, the United Kingdom, Italy and in Switzerland where its main scope of operation is neurosciences. BIAL also owns Novipharma, that is located in Switzerland.
USA
In the US, BIAL has established BIAL Biotech Investments Inc. (BIAL Biotech).
BIAL Biotech is a wholly owned subsidiary of BIAL.
Emerging Markets French West Africa
BIAL products have been marketed its medicinal products in French-Speaking African countries since 1999, and the company has been present in the region through a subsidiary located in the Ivory Coast since 2013.
Through partnerships with local promotion agents, BIAL Francophone Africa operates in 18 countries in the region including Benin, Burkina Faso, Cameroon, Chad, Congo Brazzaville, Ivory Coast, Gabon, Guinea, Mali, Mauritania, Niger, Djibouti, Central African Republic, Madagascar, Mauritius, Cape Verde, Senegal and Togo.
The BIAL portfolio highlights therapeutic solutions of the central nervous system, maternal health and women’s health as well as solutions for respiratory diseases.
Angola
BIAL has been present in Angola since the 1990s, first with export operations and, since 2008, through the creation of BIAL Angola.
BIAL Angola is one of the leading pharmaceutical companies in the country and has a wide range of products (over 40 medicinal products), from women’s and maternal health, to the treatment of infectious diseases, to neurological diseases.
Partnerships/Licencing
We work with renowned international partners to make our medicines accessible worldwide.
At Bial, we believe that bringing innovative medicines to patients everywhere requires collaboration. Through partnerships with leading pharmaceutical companies, we increase the reach of our medicines, allowing us to share our breakthroughs in neuroscience and rare diseases with patients across the globe. Check the Partnering page by clicking the button below.